2016 has been a year of IP changes and these changes have had an effect upon biotechnology as well as trade secrets.
Patents: Will the U.S. Supreme Court Grant Cert. In Ariosa v. Sequenom?
Ariosa v. Sequenom was...more
6/7/2016
/ Biotechnology ,
Defend Trade Secrets Act (DTSA) ,
DNA ,
European Patent Office ,
Myriad-Mayo ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Personalized Medicine ,
Pharmaceutical Patents ,
Popular ,
Sequenom ,
USPTO